{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T01:06:56Z","timestamp":1778980016218,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Capital Funds for Health Improvement and Research","award":["2022-2-8013 (ZXL)"],"award-info":[{"award-number":["2022-2-8013 (ZXL)"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2023YFC2411603 (ZXL)"],"award-info":[{"award-number":["2023YFC2411603 (ZXL)"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Papillary craniopharyngioma (PCP) was previously believed to occur only in adults. Sporadic pediatric PCP (PPCP), confirmed by detection of the BRAF V600E mutation, has been reported since 2018. The differences between PPCP and adult PCP (APCP) remain unclear. This comprehensive study aimed to enhance understanding of PPCP and elucidate the distinctions between PPCP and APCP. We conducted a systematic analysis of cases of PPCP and APCP, focusing on BRAF V600E mutation, methylation profiles, histology, cell proliferation, imaging features, immune microenvironment, and prognosis. This study compiled 17 cases of PPCP from 6 medical centers, constituting 3.11% of the total 546 PCP cases. Both PPCP and APCP cases exhibited the BRAF V600E mutation with no differences in methylation patterns. However, imaging showed PPCP was predominantly cystic and located beneath the diaphragma sellae with some progression to the sella. APCP typically manifested as solid lesions, primarily located in the suprasellar region, inferior to the third ventricle. PPCP histologically displayed extensive inflammatory cellular infiltration, suppurative change, and occasional small granular calcifications, whereas APCP was largely devoid of calcifications. Compared to APCP, PPCP exhibited significantly lower PD-L1 (an immune checkpoint protein expressed on tumor cells) expression and higher expression levels of CD38 (an immunosuppressive marker), S100A8\/A9 (a neutrophil marker), and MPO (myeloperoxidase, a neutrophil marker). Additionally, stromal expression of CD163 (an M2 macrophage marker) was lower in PPCP compared to APCP, while CD68 (an M1 macrophage marker), CD3 (T cell marker), and CD20 (B cell marker) expression showed no significant difference. Ki-67 expression exhibited a banded pattern on PPCP epithelium, contrasting with a punctate pattern in APCP, with significantly higher levels observed in PPCP. Postoperative prognosis did not differ between PPCP and APCP. While driver genes and methylation profiles may not differentiate PPCP from APCP, substantial discrepancies exist in tumor location, histology, imaging features, cell proliferation, and immune microenvironment.<\/jats:p>","DOI":"10.1038\/s41598-025-12662-8","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T11:30:48Z","timestamp":1753702248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparative analysis of clinical features, methylation and immune microenvironment in pediatric and adult papillary craniopharyngiomas: results from a multicenter study"],"prefix":"10.1038","volume":"15","author":[{"given":"Ning","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linbo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhong","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueling","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixiong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"12662_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis, D. N. et al. The 2021 WHO classification of tumors of the central nervous system: A summary. NEUONC 23, 1231\u20131251 (2021).","journal-title":"NEUONC"},{"key":"12662_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng.2868","volume":"46","author":"PK Brastianos","year":"2014","unstructured":"Brastianos, P. K. et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat. Genet. 46, 161\u2013165 (2014).","journal-title":"Nat. Genet."},{"key":"12662_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000002774","author":"X Wang","year":"2023","unstructured":"Wang, X. et al. Multi-omics analysis of adamantinomatous craniopharyngiomas reveals distinct molecular subgroups with prognostic and treatment response significance. Chin. Med. J. (Engl). https:\/\/doi.org\/10.1097\/cm9.0000000000002774 (2023).","journal-title":"Chin. Med. J. (Engl)"},{"key":"12662_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fgene.2018.00049","volume":"9","author":"SM Schlaffer","year":"2018","unstructured":"Schlaffer, S. M., Buchfelder, M., Stoehr, R., Buslei, R. & H\u00f6lsken, A. Rathke\u2019s cleft cyst as origin of a pediatric papillary craniopharyngioma. Front. Genet. 9, 49 (2018).","journal-title":"Front. Genet."},{"key":"12662_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00381-018-3925-4","volume":"35","author":"R Borrill","year":"2018","unstructured":"Borrill, R. et al. Papillary craniopharyngioma in a 4-year-old Girl with BRAF V600E mutation: A case report and review of the literature. Childs Nerv. Syst. 35, 169\u2013173 (2018).","journal-title":"Childs Nerv. Syst."},{"key":"12662_CR6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.4103\/neuroindia.NI_552_16","volume":"65","author":"N Din","year":"2017","unstructured":"Din, N., Tariq, M., Ahmad, Z. & Memon, W. Papillary craniopharyngioma: A clinicopathologic study of a rare entity from a major tertiary care center in Pakistan. Neurol. India. 65, 570 (2017).","journal-title":"Neurol. India"},{"key":"12662_CR7","doi-asserted-by":"publisher","first-page":"e763","DOI":"10.1097\/SCS.0000000000003176","volume":"27","author":"J Cheng","year":"2016","unstructured":"Cheng, J., Shao, Q., Pan, Z. & You, J. Analysis and long-term follow-up of the surgical treatment of children with craniopharyngioma. J. Craniofac. Surg. 27, e763\u2013e766 (2016).","journal-title":"J. Craniofac. Surg."},{"key":"12662_CR8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000048357","volume":"36","author":"YQ Zhang","year":"2002","unstructured":"Zhang, Y. Q., Wang, C. C. & Ma, Z. Y. Pediatric craniopharyngiomas: Clinicomorphological study of 189 cases. Pediatr. Neurosurg. 36, 80\u201384 (2002).","journal-title":"Pediatr. Neurosurg."},{"key":"12662_CR9","first-page":"205846012110306","volume":"10","author":"K Takagi","year":"2021","unstructured":"Takagi, K. et al. Papillary craniopharyngioma coexisting with an intratumoral abscess in a pediatric patient: A case report and review of the literature. Acta Radiol. Open. 10, 205846012110306 (2021).","journal-title":"Acta Radiol. Open."},{"key":"12662_CR10","doi-asserted-by":"publisher","first-page":"e148","DOI":"10.1016\/j.wneu.2022.05.115","volume":"165","author":"C Zhao","year":"2022","unstructured":"Zhao, C. et al. Diagnosis and management of pediatric papillary craniopharyngiomas. World Neurosurg. 165, e148\u2013e158 (2022).","journal-title":"World Neurosurg."},{"key":"12662_CR11","first-page":"1339","volume":"20","author":"A Gajjar","year":"2022","unstructured":"Gajjar, A. et al. Pediatric central nervous system cancers, version 2.2023, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc Netw. 20, 1339\u20131362 (2022).","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"12662_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.humpath.2022.01.006","volume":"122","author":"C Bernardo","year":"2022","unstructured":"Bernardo, C. et al. Molecular pathology of the non-luminal Ba\/Sq-like and Sc\/NE-like classes of urothelial tumours: An integrated immunohistochemical analysis. Hum. Pathol. 122, 11\u201324 (2022).","journal-title":"Hum. Pathol."},{"key":"12662_CR13","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/PAS.0000000000001023","volume":"42","author":"PD Johann","year":"2018","unstructured":"Johann, P. D. et al. Sellar region atypical teratoid\/rhabdoid tumors (ATRT) in adults display DNA methylation profiles of the ATRT-MYC subgroup. Am. J. Surg. Pathol. 42, 506\u2013511 (2018).","journal-title":"Am. J. Surg. Pathol."},{"key":"12662_CR14","doi-asserted-by":"publisher","first-page":"E241","DOI":"10.1093\/neuros\/nyy614","volume":"85","author":"DW Fults","year":"2018","unstructured":"Fults, D. W. Commentary: A clinical rule for preoperative prediction of BRAF mutation status in craniopharyngioma. Neurosurg 85, E241\u2013E242 (2018).","journal-title":"Neurosurg"},{"key":"12662_CR15","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2016.9.FOCUS16325","volume":"41","author":"JC Martinez-Gutierrez","year":"2016","unstructured":"Martinez-Gutierrez, J. C. et al. Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy. FOC 41, E2 (2016).","journal-title":"FOC"},{"key":"12662_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/nan.12201","volume":"41","author":"L Schweizer","year":"2015","unstructured":"Schweizer, L. et al. BRAF V 600 E\u2009analysis for the differentiation of papillary craniopharyngiomas and R athke\u2019s cleft cysts. Neuropathol. Appl. Neurobio. 41, 733\u2013742 (2015).","journal-title":"Neuropathol. Appl. Neurobio."},{"key":"12662_CR17","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3171\/jns.1995.83.2.0206","volume":"83","author":"TB Crotty","year":"1995","unstructured":"Crotty, T. B. et al. Papillary craniopharyngioma: A clinicopathological study of 48 cases. JNS 83, 206\u2013214 (1995).","journal-title":"JNS"},{"key":"12662_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-019-0125-9","volume":"5","author":"HL M\u00fcller","year":"2019","unstructured":"M\u00fcller, H. L. et al. Craniopharyngioma. Nat. Rev. Dis. Primers 5, 1\u201319 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"12662_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11060-015-1757-6","volume":"123","author":"JH Kim","year":"2015","unstructured":"Kim, J. H., Paulus, W. & Heim, S. BRAF V600E mutation is a useful marker for differentiating rathke\u2019s cleft cyst with squamous metaplasia from papillary craniopharyngioma. J. Neurooncol. 123, 189\u2013191 (2015).","journal-title":"J. Neurooncol"},{"key":"12662_CR20","doi-asserted-by":"publisher","first-page":"R139","DOI":"10.1530\/EJE-15-0957","volume":"174","author":"PK Brastianos","year":"2016","unstructured":"Brastianos, P. K., Santagata, S. Endocrine tumors: BRAF V600E mutations in papillary craniopharyngioma. Eur. J. Endocrinol. 174, R139\u2013R144 (2016).","journal-title":"Eur. J. Endocrinol."},{"key":"12662_CR21","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.3171\/2016.9.FOCUS16304","volume":"41","author":"R Prieto","year":"2016","unstructured":"Prieto, R. et al. Craniopharyngioma adherence: A comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors. FOC 41, E13\u2013E13 (2016).","journal-title":"FOC"},{"key":"12662_CR22","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2010.2.FOCUS09318","volume":"28","author":"G Zada","year":"2010","unstructured":"Zada, G., Lin, N., Ojerholm, E., Ramkissoon, S. & Laws, E. R. Craniopharyngioma and other cystic epithelial lesions of the sellar region: A review of clinical, imaging, and histopathological relationships. FOC 28, E4 (2010).","journal-title":"FOC"},{"key":"12662_CR23","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s00381-019-04178-0","volume":"35","author":"M Chen","year":"2019","unstructured":"Chen, M., Zhang, Z., Yang, M. & Li, S. T. Prediction of calcification tendency in pediatric cystic adamantinomatous craniopharyngioma by using inflammatory markers, hormone markers, and radiological appearances. Childs Nerv. Syst. 35, 1173\u20131180 (2019).","journal-title":"Childs Nerv. Syst."},{"key":"12662_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3171\/jns.2005.103.5.0837","volume":"103","author":"MJ Binning","year":"2005","unstructured":"Binning, M. J., Gottfried, O. N., Osborn, A. G. & Couldwell, W. T. Rathke cleft cyst intracystic nodule: A characteristic magnetic resonance imaging finding. JNS 103, 837\u2013840 (2005).","journal-title":"JNS"},{"key":"12662_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3171\/jns.2004.101.4.0577","volume":"101","author":"RJ Benveniste","year":"2004","unstructured":"Benveniste, R. J. et al. Surgery for Rathke cleft cysts: Technical considerations and outcomes. JNS 101, 577\u2013584 (2004).","journal-title":"JNS"},{"key":"12662_CR26","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3389\/fimmu.2019.01187","volume":"10","author":"KA Hogan","year":"2019","unstructured":"Hogan, K. A., Chini, C. C. S. & Chini, E. N. The Multi-faceted Ecto-enzyme CD38: Roles in immunomodulation, cancer, aging, and metabolic diseases. Front. Immunol. 10, 1187 (2019).","journal-title":"Front Immunol"},{"key":"12662_CR27","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/cells9010026","volume":"9","author":"YJ Wo","year":"2019","unstructured":"Wo, Y. J. et al. The roles of CD38 and CD157 in the solid tumor microenvironment and cancer immunotherapy. Cells 9, 26 (2019).","journal-title":"Cells"},{"key":"12662_CR28","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/neuonc\/noy035","volume":"20","author":"S Coy","year":"2018","unstructured":"Coy, S. et al. Multiplexed immunofluorescence reveals potential PD-1\/PD-L1 pathway vulnerabilities in craniopharyngioma. NEUONC 20, 1101\u20131112 (2018).","journal-title":"NEUONC"},{"key":"12662_CR29","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. S100A8\/A9 in inflammation. Front. Immunol. 9, 1298 (2018).","journal-title":"Front. Immunol."},{"key":"12662_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-022-05400-x","volume":"612","author":"R Xue","year":"2022","unstructured":"Xue, R. et al. Liver tumour immune microenvironment subtypes and neutrophil heterogeneity. Nature 612, 141\u2013147 (2022).","journal-title":"Nature"},{"key":"12662_CR31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ccell.2023.01.002","volume":"41","author":"IL Linde","year":"2023","unstructured":"Linde, I. L. et al. Neutrophil-activating therapy for the treatment of cancer. Cancer Cell. 41, 356\u2013372e10 (2023).","journal-title":"Cancer Cell."},{"key":"12662_CR32","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","volume":"20","author":"S Jaillon","year":"2020","unstructured":"Jaillon, S. et al. Neutrophil diversity and plasticity in tumour progression and therapy. Nat. Rev. Cancer. 20, 485\u2013503 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"12662_CR33","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s13258-019-00856-0","volume":"41","author":"SH Hwang","year":"2019","unstructured":"Hwang, S. H., Ahn, J. H. & Lee, M. Upregulation of S100A9 contributes to the acquired resistance to BRAF inhibitors. Genes Genomics. 41, 1273\u20131280 (2019).","journal-title":"Genes Genomics"},{"key":"12662_CR34","doi-asserted-by":"publisher","first-page":"e212","DOI":"10.1016\/j.wneu.2019.02.212","volume":"127","author":"D Lin","year":"2019","unstructured":"Lin, D., Wang, Y., Zhou, Z. & Lin, Z. Immune microenvironment of primary and recurrent craniopharyngiomas: A study of the differences and clinical significance. World Neurosurg. 127, e212\u2013e220 (2019).","journal-title":"World Neurosurg."},{"key":"12662_CR35","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani, A., Allavena, P., Marchesi, F. & Garlanda, C. Macrophages as tools and targets in cancer therapy. Nat. Rev. Drug Discov. 21, 799\u2013820 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"12662_CR36","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"A Christofides","year":"2022","unstructured":"Christofides, A. et al. The complex role of tumor-infiltrating macrophages. Nat. Immunol. 23, 1148\u20131156 (2022).","journal-title":"Nat. Immunol."},{"key":"12662_CR37","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1002\/cncr.32197","volume":"125","author":"TA Juratli","year":"2019","unstructured":"Juratli, T. A. et al. Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations. Cancer 125, 2910\u20132914 (2019).","journal-title":"Cancer"},{"key":"12662_CR38","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s11102-015-0663-4","volume":"19","author":"SJB Aylwin","year":"2015","unstructured":"Aylwin, S. J. B., Bodi, I. & Beaney, R. Pronounced response of papillary craniopharyngioma to treatment with vemurafenib, a BRAF inhibitor. Pituitary 19, 544\u2013546 (2015).","journal-title":"Pituitary"},{"key":"12662_CR39","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1007\/s00701-017-3311-0","volume":"159","author":"E Rostami","year":"2017","unstructured":"Rostami, E. et al. Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy. Acta Neurochir. 159, 2217\u20132221 (2017).","journal-title":"Acta Neurochir."},{"key":"12662_CR40","doi-asserted-by":"publisher","first-page":"djv310","DOI":"10.1093\/jnci\/djv310","volume":"108","author":"PK Brastianos","year":"2015","unstructured":"Brastianos, P. K. et al. Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy. JNCI J. 108, djv310 (2015).","journal-title":"JNCI J."},{"key":"12662_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2217\/cns-2016-0034","volume":"6","author":"A Roque","year":"2017","unstructured":"Roque, A. & Odia, Y. BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors. CNS Oncol. 6, 95\u201399 (2017).","journal-title":"CNS Oncol."},{"key":"12662_CR42","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.3171\/2019.10.FOCUS19728","volume":"48","author":"S Soldozy","year":"2020","unstructured":"Soldozy, S. et al. Endoscopic endonasal surgery outcomes for pediatric craniopharyngioma: A systematic review. FOC 48, E6 (2020).","journal-title":"FOC"},{"key":"12662_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.clineuro.2007.10.013","volume":"110","author":"XE Shi","year":"2007","unstructured":"Shi, X. E., Wu, B., Fan, T., Zhou, Z. Q. & Zhang, Y. L. Craniopharyngioma: Surgical experience of 309 cases in China. Clin. Neurol. Neurosurg. 110, 151\u2013159 (2007).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"12662_CR44","doi-asserted-by":"publisher","first-page":"e277","DOI":"10.1016\/j.wneu.2019.10.039","volume":"134","author":"D Mazzatenta","year":"2019","unstructured":"Mazzatenta, D. et al. Outcome of endoscopic endonasal surgery in pediatric craniopharyngiomas. World Neurosurg. 134, e277\u2013e288 (2019).","journal-title":"World Neurosurg."},{"key":"12662_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.wneu.2017.02.095","volume":"102","author":"X Shi","year":"2017","unstructured":"Shi, X. et al. Outcome of radical surgical resection for craniopharyngioma with hypothalamic preservation: A single-center retrospective study of 1054 patients. World Neurosurg. 102, 167\u2013180 (2017).","journal-title":"World Neurosurg."},{"key":"12662_CR46","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1227\/NEU.0b013e31821a872d","volume":"69","author":"RE Elliott","year":"2011","unstructured":"Elliott, R. E., Jane, J. A. & Wisoff, J. H. Surgical management of craniopharyngiomas in children: Meta-analysis and comparison of transcranial and transsphenoidal approaches. Neurosurg 69, 630\u2013643 (2011).","journal-title":"Neurosurg"},{"key":"12662_CR47","doi-asserted-by":"publisher","first-page":"698150","DOI":"10.3389\/fonc.2021.698150","volume":"11","author":"S Boekhoff","year":"2021","unstructured":"Boekhoff, S. et al. Cerebral infarction in childhood-onset craniopharyngioma patients: Results of KRANIOPHARYNGEOM 2007. Front Oncol 11,  698150 (2021).","journal-title":"Front Oncol"},{"key":"12662_CR48","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3892\/ol.2013.1293","volume":"5","author":"Q ZHONG","year":"2013","unstructured":"ZHONG, Q. & YUAN, S. Total resection of a solitary fibrous tumor of the Sellar diaphragm: A case report. Oncol. Lett. 5, 1783\u20131786 (2013).","journal-title":"Oncol. Lett."},{"key":"12662_CR49","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/jnen\/nly083","volume":"77","author":"Y Liu","year":"2018","unstructured":"Liu, Y. et al. Pathological relationship between adamantinomatous craniopharyngioma and adjacent structures based on QST classification. J. Neuropathol. Exp. Neurol. 77, 1017\u20131023 (2018).","journal-title":"J. Neuropathol. Exp. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12662-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12662-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12662-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T04:27:34Z","timestamp":1757305654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12662-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12662"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12662-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"15 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was granted by the Ethics Committee of Sanbo Brain Hospital, Capital Medical University (No. SBNK-YJ-2023-035-01). All included patients provided signed informed consent to participate in the study. For the minor patients included in this study, informed consent was obtained from their parents and\/or legal guardians. All parents and\/or legal guardians provided consent for participation in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"27422"}}